Welcure Drugs & Pharmaceuticals Ltd secures ₹517 Crore Global Sourcing Mandate

Welcure Drugs & Pharmaceuticals Limited ("Welcure") has executed a definitive mandate for third-party sourcing and procurement services aggregating ~₹517 crore with an overseas client, Fortune Sagar Impex Company Limited, Thailand.

The company will receive fixed 5 % commission on cost of goods, estimated service income ~₹25.85 crore to be recognised over FY 2025-26.

The mandate enhances Welcure's fee-based portfolio without incremental balance-sheet exposure. The Company will provide further updates, as and when successive call-offs are activated.

Shares of WELCURE DRUGS & PHARMACEUTICALS LTD. was last trading in BSE at Rs. 13.09 as compared to the previous close of Rs. 12.47. The total number of shares traded during the day was 243115 in over 312 trades.

The stock hit an intraday high of Rs. 13.09 and intraday low of 12.02. The net turnover during the day was Rs. 3125440.00.

Source : Equity Bulls

Keywords

WELCUREDRUGSandPHARMACEUTICALS INE331C01017 ProcurementServices Sourcing OrderWin